Overview
Kazuya Yoshida practices in Fushimi, Japan. Mr. Yoshida is rated as an Experienced expert by MediFind in the treatment of Benign Essential Blepharospasm. His top areas of expertise are Drug Induced Dyskinesia, Focal Dystonia, Movement Disorders, Progressive Hemifacial Atrophy, and Microvascular Decompression.
His clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Benign Essential Blepharospasm.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Drug Induced DyskinesiaMr. Yoshida isDistinguished. Learn about Drug Induced Dyskinesia.
- Focal DystoniaMr. Yoshida isDistinguished. Learn about Focal Dystonia.
- Advanced
- Movement DisordersMr. Yoshida isAdvanced. Learn about Movement Disorders.
- Experienced
- Benign Essential BlepharospasmMr. Yoshida isExperienced. Learn about Benign Essential Blepharospasm.
- DysarthriaMr. Yoshida isExperienced. Learn about Dysarthria.
- Guillain-Barre SyndromeMr. Yoshida isExperienced. Learn about Guillain-Barre Syndrome.
- Localized SclerodermaMr. Yoshida isExperienced. Learn about Localized Scleroderma.
- Microvascular DecompressionMr. Yoshida isExperienced. Learn about Microvascular Decompression.
- Progressive Hemifacial AtrophyMr. Yoshida isExperienced. Learn about Progressive Hemifacial Atrophy.